Kewajiban jangka dawa perusahaan: CorVel Corp (CRVL)

Tandha merek CorVel Healthcare (CRVL)

CorVel Corporation (CRVL) maintains business stability through deeply integrated IT solutions that create high switching costs for clients. This GURU.Markets chart contains data on the company's long-term debt, where the indicator is fixed at 0.02. Insurer confidence is based on analytical precision and cost minimization. The synergy between medical professionals and programmers, combined with transparent career growth, guarantees the corporation's sustainable development.

Utang jangka dawa perusahaan CorVel Corp (CRVL): kanggo periode 04.07.2022 - 30.10.2026
Produk seri CorVel

This indicator measures the total volume of liabilities with a maturity of more than one year, allowing for an assessment of the issuer's long-term solvency and credit risk. By analyzing the change in the organization's long-term financial debt at the 0.02 level, an investor can evaluate the extent to which the scaling of cloud AI technologies at CorVel Corporation (CRVL) is funded by borrowed capital, which directly impacts future profitability and dividend potential.

Analisis pesaing CorVel Corporation

Silihan lan utang jangka dawa perusahaan VEEV|DOCS - Utang jangka dawa perusahaan|HealthEquity Inc (HQY) - Kewajiban jangka dawa perusahaan|WAY: Utang jangka dawa perusahaan|Utang jangka dawa Privia Medical Group (PRVA)|HURN (Huron Consulting Group) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan CERT (certara.com)|Utang jangka dawa perusahaan OMCL|Kewajiban jangka dawa perusahaan GoodRx Inc GDRX|Utang jangka dawa perusahaan Schrödinger Inc. SDGR|Phreesia Health (PHR) - Utang jangka dawa|OMDA - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan EVH (evolenthealth.com)|HSTM (HealthStream) - Kewajiban jangka dawa perusahaan|DH (Definitive Healthcare Corp) - Utang jangka dawa perusahaan|CCSI (Consensus) - Utang jangka dawa perusahaan|Utang jangka dawa Agilon Health Corp AGL|Utang jangka dawa perusahaan Absci (ABSI)|Utang jangka dawa perusahaan SY (soyoung.com)|National Research Corp - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan SPOK|OptimizeRx Corp. - Utang jangka dawa perusahaan|TruBridge Corp (TBRG) - Kewajiban jangka dawa perusahaan|Simulations Plus, Inc. (SLP) - Utang jangka dawa perusahaan|Utang jangka dawa SOPHiA GENETICS (SOPH)|Utang jangka dawa perusahaan Health Catalyst|CCLD: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Research Solutions (RSSS)|DLHC: Kewajiban jangka dawa|Utang jangka dawa perusahaan OneMedNet ONMD|scienture.com (SCNX) - Utang jangka dawa|HCTI - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan ISPC (iSpecimen Inc.)|BFRG: Utang jangka dawa perusahaan|SCWorx Inc (WORX) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan MSPR|ICCT (iCoreConnect Corp) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan MEDS|Gunggunge utang jangka dawa Orgenesis Inc|Utang jangka dawa perusahaan R1 RCM RCM|Sharecare Inc (SHCR) - Utang jangka dawa|STRM - Utang jangka dawa perusahaan|SYRA (syrahealth.com) - Tanggungan utang jangka dawa perusahaan|AMEH: Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Model N Inc|Utang jangka dawa perusahaan NextGen